Patients with uncomplicated chronic hypertension who avoid preeclampsia show only marginally higher risk for severe maternal ...

OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...

As sustainability becomes a critical focus across industries, structural engineering is undergoing significant ...

Idaho National Laboratory signed agreements with Boise State University to deepen collaborative research and development ...

The acceleration of e-scooters should be limited to a maximum of 2 m/s2, in line with BS EN 17128:2020. Limiting acceleration of an e-scooter (along with speed and mass) is a more effective safety ...

Boston Properties (NYSE:BXP) reported its fourth-quarter 2024 earnings, revealing a significant miss on earnings per share ...